John H. Yim

3.8k citations

79 papers · 2.6k indexed · h-index 30

Impact in

Nephrology top 2%
- Parathyroid Disorders and Treatments
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cytokine Signaling Pathways and Interactions

Papers in

Nephrology 10
- Parathyroid Disorders and Treatments 10
Oncology 37
- Cytokine Signaling Pathways and Interactions 9
- Cancer Immunotherapy and Biomarkers 7

Co-authors: Sally E. Carty Jennifer B. Ogilvie Michael T. Stang Peter P. Lee Gerard M. Doherty Wei Wen Kelly L. McCoy Diana L. Simons
Journals: Surgery (10 papers)Journal of Clinical Oncology (5 papers)Annals of Surgical Oncology (4 papers)Journal of the American College of Surgeons (4 papers)World Journal of Surgery (3 papers)
Partner nations: United States China Hong Kong

In The Last Decade

John H. Yim

77 papers receiving 2.6k citations

Peers

Countries citing papers authored by John H. Yim

Since Specialization

Citations

This map shows the geographic impact of John H. Yim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Yim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Yim more than expected).

Fields of papers citing papers by John H. Yim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Yim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Yim. The network helps show where John H. Yim may publish in the future.

Co-authors

The 25 scholars most cited alongside John H. Yim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John H. Yim Line = papers co-authored together John H. Yim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Therapeutic Potential of Baicalein in Endometrial Cancer: Suppression of mTOR Signaling and Synergy with Metformin International Journal of Molecular Sciences ·Kim Jeongmi, Wei Wen, Jin Yan, Yuwen Cen, Chuanxi, Ernest Han, John H. Yim	2025	0
2	PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer Cell Reports Medicine ·Lei Wang, Weihua Guo, Alma Nwaigwe, Jiangnan Yu, Jiayi Tan, Diana L. Simons, Márta Farkas, Xinyu Liu, Qian Zhou, Yi-Zi Zheng, Elham Khanniri, John H. Yim, James Waisman, Peter P. Lee	2024	46
3	Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer JCI Insight ·Colt A. Egelston, Weihua Guo, Jiayi Tan, Christian Avalos, Diana L. Simons, Kushum Kunwar, Yinghui Huang, Michael S. Nelson, Tanja Krunić, Daniel Schmolze, John H. Yim, Laura Kruper, Laleh G. Melstrom, Kim Margolin, Joanne Mortimer, Yuan Yuan, James Waisman, Peter P. Lee	2022	25
4	Insurance Status Predicts Survival in Women with Breast Cancer: Results of Breast and Cervical Cancer Treatment Program in California Annals of Surgical Oncology ·Rebecca A. Nelson, E. M. Campagnolo, Veronica Jones, Joanne Mortimer, Sreeraj Rajappan, Leslie Taylor, Xuhui Lee, John H. Yim, Laura Kruper	2020	9
5	Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer Nature Immunology ·Lei Wang, Diana L. Simons, Xuyang Lu, Travis Y. Tu, Shawn T. Solomon, Ruo‐Qian Wang, F. Nwankpa, Christian Avalos, Daniel Schmolze, John H. Yim, James Waisman, Peter P. Lee	2019	125
6	Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer Translational Oncology ·Wei Wen, Ernest Han, Thanh H. Dellinger, Jun Wu, 多喜夫岡田, Ralf Buettner, David Horne, Richard Jove, John H. Yim	2019	9
7	Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics Clinical Cancer Research ·John H. Yim, Audrey H. Choi, Arthur X. Li, Hanjun Qin, Sue Chang, Duane Paiva de Moraes, Peiguo Chu, Jingcan Zhang, Daniel Schmolze, Zaets Tl, Janaína Monique Ferreira de Souza, Valeriy Poroyko, Gonçalo Gomes Araújo, Alysha Baker, Jinhui Wang, Xiwei Wu, Gerd P. Pfeifer, Yuman Fong, Maria A. Hahn	2018	32
8	Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression Nature Communications ·Colt A. Egelston, Christian Avalos, Travis Y. Tu, Diana L. Simons, H. Qawar, Jae Yoon Jung, Laleh G. Melstrom, Kim Margolin, John H. Yim, Laura Kruper, Joanne Mortimer, Peter P. Lee	2018	97
9	IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer Cancer Research ·Lei Wang, Andrea K. Miyahira, Diana L. Simons, Xuyang Lu, Andrew Y. Chang, Carrie Wang, Maria Suni, Vernon C. Maino, Frederick M. Dirbas, John H. Yim, James Waisman, Peter P. Lee	2016	37
10	Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2− and ER+HER2+) breast cancers The Journal of Steroid Biochemistry and Molecular Biology ·Noriko Kanaya, George Somlo, Jun Wu, Paul Frankel, Masaya Kai, Xueli Liu, Debasmita Ghosh, Duc Nguyen, 孝雄富尾, Χριστίνα Μαγνήσαλη, Olivier Renaudau, Laura Kruper, Rosa Almache, Behnam Badie, John H. Yim, Yuan Yuan, Arti Hurria, R. Canário, Joanne Mortimer, Shiuan Chen	2016	21
11	Time to Treatment: Measuring Quality Breast Cancer Care Annals of Surgical Oncology ·Sreeraj Rajappan, Rebecca A. Nelson, 第回進化経済学会大会運営委員会, Veronica Jones, Lily Lai, Joanne Mortimer, Leslie Taylor, Rosa Almache, John H. Yim, Laura Kruper	2016	76
12	IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition Cancer Biology & Therapy ·Michaele J. Armstrong, Michael T. Stang, Yujing Liu, Jin Yan, Woranat Suntornsantoon, John H. Yim	2015	27
13	Identification of a Natural Compound by Cell-Based Screening That Enhances Interferon Regulatory Factor-1 Activity and Causes Tumor Suppression Molecular Cancer Therapeutics ·Jinbo Gao, Yujun Wang, Yuwen Cen, Jin Yan, Maheswari Senthil, Yasir Akmal, Claudia Kowolik, Julia Kang, David Lu, Ming Zhao, Zhi‐Xiu Lin, Christopher H.K. Cheng, M.L. Richard Yip, John H. Yim	2011	15
14	Interferon Regulatory Factor 1 (IRF-1) induces p21WAF1/CIP1 dependent cell cycle arrest and p21WAF1/CIP1 independent modulation of survivin in cancer cells Cancer Letters ·Michaele J. Armstrong, Michael T. Stang, Ye Liu, Jinbo Gao, Bao‐Guo Ren, Brian S. Zuckerbraun, Raja S. Mahidhara, Yuwen Cen, Woranat Suntornsantoon, John H. Yim	2011	29
15	The Adrenal Mass: Correlation of Histopathology with Imaging Annals of Surgical Oncology ·Linwah Yip, Mitchell Tublin, John L. Falcone, A. Marini, Michael T. Stang, Jennifer B. Ogilvie, Sally E. Carty, John H. Yim	2009	41
16	Same-day ultrasound guidance in reoperation for locally recurrent papillary thyroid cancer Surgery ·Kelly L. McCoy, John H. Yim, Mitchell Tublin, Lynn A. Burmeister, Jennifer B. Ogilvie, Sally E. Carty	2007	28
17	The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size Surgery ·Kelly L. McCoy, Noel Jabbour, Jennifer B. Ogilvie, N. Paul Ohori, Sally E. Carty, John H. Yim	2007	182
18	IRF-1 mediated apoptosis is FADD and caspase 8 dependent Journal of the American College of Surgeons ·Michael T. Stang, Michaele J. Armstrong, Jenny Himongala, TOM PRICE, I G A M Suartika, John H. Yim	2006	1
19	The Role of Interferon Regulatory Factor-1 and Interferon Regulatory Factor-2 in IFN- γ Growth Inhibition of Human Breast Carcinoma Cell Lines Journal of Interferon & Cytokine Research ·John H. Yim, K. R. Dorik, Jennifer K. Lowney, Susan Wu, Judith M. Connett, Gerard M. Doherty	2003	35
20	Underlying pathology in mammary Paget's disease Annals of Surgical Oncology ·John H. Yim, Mark R. Wick, Gordon W. Philpott, Jeffrey A. Norton, Gerard M. Doherty	1997	78

About John H. Yim

John H. Yim is a scholar working on Nephrology, Oncology, Cancer Research, Reproductive Medicine and Immunology, having authored 79 papers that have together received 2.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Parathyroid Disorders and Treatments (10 papers), Cytokine Signaling Pathways and Interactions (9 papers), Thyroid Cancer Diagnosis and Treatment (9 papers), Thyroid and Parathyroid Surgery (8 papers), Ovarian cancer diagnosis and treatment (8 papers), interferon and immune responses (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Nephrology (322 citations), Oncology (1.0k citations), Cancer Research (476 citations), Endocrinology, Diabetes and Metabolism (510 citations) and Immunology (585 citations). John H. Yim has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Sally E. Carty, Jennifer B. Ogilvie, Michael T. Stang, Peter P. Lee, Gerard M. Doherty, Wei Wen, Kelly L. McCoy, Diana L. Simons, Ernest Han and Linwah Yip. Their work appears in journals such as Surgery, Journal of Clinical Oncology, Annals of Surgical Oncology, Journal of the American College of Surgeons and World Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact